MedTrace Logo

The Medacta International SMS Post-Marketing Surveillance Study

NCT02748408 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.

Conditions

  • Arthrosis
  • Traumatic Arthritis
  • Rheumatoid Polyarthritis
  • Congenital Hip Dysplasia
  • Avascular Necrosis of the Femoral Head

Interventions

DEVICE

SMS femoral stem

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2032-07-31
Completion
2032-07-31

Countries

  • Austria
  • Italy
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02748408 on ClinicalTrials.gov